Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
Mom warns of Christmas gift hazard as daughter recovers in hospital- Step by step instructions to Guarantee the Strength and Life span of Your Pre-assembled Home
- People who talk with their hands seem more clear and persuasive – new research
- SUVs Known for Their Looks As opposed to Their Capacity
- UN rights chief: Israel's new Gaza aid agency rules 'outrageous'
- Czech Republic's new premier: No money for Ukraine
- The Most Enrapturing Authentic Milestones to Visit
- Why do people get headaches and migraines? A child neurologist explains the science of head pain and how to treat it
- Vote in favor of the Web-based Work out schedule to Keep You Fit and Sound
